Literature DB >> 1740486

The modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration.

P D'Amour1, J Palardy, G Bahsali, L E Mallette, A DeLéan, R Lepage.   

Abstract

Twenty normal individuals received 2-h iv infusions of CaCl2 and Na2 ethylenediamine tetra-acetate, with sampling every 15 min. PTH was measured by means of an intact hormone assay (I) and two carboxylterminal assays structured to react mostly with mid (M) or late (L) carboxylterminal fragments. A mathematical model was used to fit the sigmoidal relationship between ionized calcium (CA++) and PTH values. The influence of Ca++ on circulating PTH immunoheterogeneity was assessed via changes in L/I, M/I, and M/L ratios. Results are reported as means +/- SD. Response to hypocalcemia was highest with M (57.8 +/- 26.4 pmol/L, P less than 0.005 vs. L or I) and higher with L (20.1 +/- 5.6 pmol/L; P less than 0.0005 vs. I) than with I (14.1 +/- 6.4 pmol/L). L/I, M/I, and M/L decreased from 2.43 +/- 0.56 to 1.54 +/- 0.19 (P less than 0.0005), 8.44 +/- 2.38 to 4.36 +/- 4.07 (P less than 0.0005), and 3.49 +/- 0.71 to 2.86 +/- 0.76 (P less than 0.005), respectively, during Na2 ethylenediamine tetra-acetate infusion. Nonsuppressible PTH was again higher with M (13.7 +/- 4.8 pmol/L; P less than 0.0005 vs. L or I) and higher with L (2.8 +/- 0.7 pmol/L, P less than 0.0005 vs. I) than with I (0.5 +/- 0.3 pmol/L). L/I, M/I, and M/L ratios increased from 2.47 +/- 0.97 to 5.35 +/- 2.09 (P less than 0.0005), 8.90 +/- 3.10 to 29.56 +/- 14.89 (P less than 0.0005), and 3.62 +/- 0.90 to 5.30 +/- 1.91 (P less than 0.005) during CaCl2 infusion. The set-point for PTH stimulation by calcium was similar for M (1.15 +/- 0.035 mmol/L) and L (1.175 +/- 0.041 mmol/L) but significantly higher with the I assay (1.184 +/- 0.31 mmol/L; P less than 0.0005 vs. M). The M/I, L/I, and M/L ratio set-points were similar at 1.28 +/- 0.01, 1.27 +/- 0.01, and 1.29 +/- 0.02 mmol/L. Thus, even if proportionately more intact PTH and less carboxylterminal fragments are produced and secreted during hypocalcemia, the latter still predominate in the circulation. Furthermore, at high calcium values, secretion of fragments is less well inhibited than that of intact hormone. The lower secretion and higher ratio set-points suggest that the secretion and intracellular degradation of PTH have different sensitivities to inhibition by calcium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740486     DOI: 10.1210/jcem.74.3.1740486

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  High-Resolution Mass Spectrometry for the Measurement of PTH and PTH Fragments: Insights into PTH Physiology and Bioactivity.

Authors:  Candice Z Ulmer; Kittrawee Kritmetapak; Ravinder J Singh; Hubert W Vesper; Rajiv Kumar
Journal:  J Am Soc Nephrol       Date:  2022-04-08       Impact factor: 14.978

2.  Decreased expression of calcium receptor in parathyroid tissue in patients with hyperparathyroidism secondary to chronic renal failure.

Authors:  María Martín-Salvago; José L Villar-Rodríguez; Alfonso Palma-Alvarez; Antonio Beato-Moreno; Hugo Galera-Davidson
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

3.  Immunoheterogeneity of parathyroid hormone pre- and postoperatively in primary hyperparathyroidism.

Authors:  A Bergenfelz; S Valdermarsson; B Ahrén
Journal:  Langenbecks Arch Chir       Date:  1995

4.  Comparison of the suppressive effect of two doses (500 mg vs 1500 mg) of oral calcium on parathyroid hormone secretion and on urinary cyclic AMP.

Authors:  J Guillemant; S Guillemant
Journal:  Calcif Tissue Int       Date:  1993-11       Impact factor: 4.333

5.  Higher Proportion of Non-1-84 PTH Fragments in Peritoneal Dialysis Patients Compared to Hemodialysis Patients Using Solutions Containing 1.75 mmol/l Calcium.

Authors:  Carmen Sánchez-González; Maria Luisa Gonzalez-Casaus; Víctor Lorenzo Sellares; Marta Albalate; José-Vicente Torregrosa; Sebastian Mas; Alberto Ortiz; Mariano Rodriguez; Emilio Gonzalez-Parra
Journal:  Front Physiol       Date:  2018-11-20       Impact factor: 4.566

Review 6.  Parathyroid Hormone Measurement in Chronic Kidney Disease: From Basics to Clinical Implications.

Authors:  Kittrawee Kritmetapak; Chatlert Pongchaiyakul
Journal:  Int J Nephrol       Date:  2019-09-17

7.  Chemical Characterization and Quantification of Circulating Intact PTH and PTH Fragments by High-Resolution Mass Spectrometry in Chronic Renal Failure.

Authors:  Kittrawee Kritmetapak; Louis A Losbanos; Jolaine M Hines; Katherine L O'Grady; Candice Z Ulmer; Hubert W Vesper; Felicity T Enders; Ravinder J Singh; Rajiv Kumar
Journal:  Clin Chem       Date:  2021-06-01       Impact factor: 8.327

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.